233 related articles for article (PubMed ID: 10961862)
21. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.
Shioda T; Kato H; Ohnishi Y; Tashiro K; Ikegawa M; Nakayama EE; Hu H; Kato A; Sakai Y; Liu H; Honjo T; Nomoto A; Iwamoto A; Morimoto C; Nagai Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6331-6. PubMed ID: 9600965
[TBL] [Abstract][Full Text] [Related]
22. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1.
Nardelli B; Tiffany HL; Bong GW; Yourey PA; Morahan DK; Li Y; Murphy PM; Alderson RF
J Immunol; 1999 Jan; 162(1):435-44. PubMed ID: 9886417
[TBL] [Abstract][Full Text] [Related]
24. Natural truncation of the chemokine MIP-1 beta /CCL4 affects receptor specificity but not anti-HIV-1 activity.
Guan E; Wang J; Roderiquez G; Norcross MA
J Biol Chem; 2002 Aug; 277(35):32348-52. PubMed ID: 12070155
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
[TBL] [Abstract][Full Text] [Related]
26. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
Kaufmann A; Salentin R; Gemsa D; Sprenger H
J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
[TBL] [Abstract][Full Text] [Related]
27. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.
Chou CC; Fine JS; Pugliese-Sivo C; Gonsiorek W; Davies L; Deno G; Petro M; Schwarz M; Zavodny PJ; Hipkin RW
Br J Pharmacol; 2002 Nov; 137(5):663-75. PubMed ID: 12381680
[TBL] [Abstract][Full Text] [Related]
29. Identification of C-C chemokine receptor 1 (CCR1) as the monocyte hemofiltrate C-C chemokine (HCC)-1 receptor.
Tsou CL; Gladue RP; Carroll LA; Paradis T; Boyd JG; Nelson RT; Neote K; Charo IF
J Exp Med; 1998 Aug; 188(3):603-8. PubMed ID: 9687537
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
[TBL] [Abstract][Full Text] [Related]
31. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
[TBL] [Abstract][Full Text] [Related]
32. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
Pease JE; Wang J; Ponath PD; Murphy PM
J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
[TBL] [Abstract][Full Text] [Related]
33. Chemokine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection.
Salentin R; Gemsa D; Sprenger H; Kaufmann A
J Leukoc Biol; 2003 Aug; 74(2):252-9. PubMed ID: 12885942
[TBL] [Abstract][Full Text] [Related]
34. Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines.
Gouwy M; De Buck M; Pörtner N; Opdenakker G; Proost P; Struyf S; Van Damme J
Eur J Immunol; 2015 Jan; 45(1):101-12. PubMed ID: 25345597
[TBL] [Abstract][Full Text] [Related]
35. Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1-dependent chemokines.
Ko J; Jang SW; Kim YS; Kim IS; Sung HJ; Kim HH; Park JY; Lee YH; Kim J; Na DS
FASEB J; 2004 May; 18(7):890-2. PubMed ID: 15001559
[TBL] [Abstract][Full Text] [Related]
36. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
[TBL] [Abstract][Full Text] [Related]
37. Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans.
Ali S; Palmer AC; Banerjee B; Fritchley SJ; Kirby JA
J Biol Chem; 2000 Apr; 275(16):11721-7. PubMed ID: 10766793
[TBL] [Abstract][Full Text] [Related]
38. Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5.
Larsen O; Schuermans S; Walser A; Louka S; Lillethorup IA; Våbenø J; Qvortrup K; Proost P; Rosenkilde MM
FEBS Lett; 2023 Dec; 597(24):3049-3060. PubMed ID: 37994578
[TBL] [Abstract][Full Text] [Related]
39. CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.
Schols D; Proost P; Struyf S; Wuyts A; De Meester I; Scharpé S; Van Damme J; De Clercq E
Antiviral Res; 1998 Oct; 39(3):175-87. PubMed ID: 9833958
[TBL] [Abstract][Full Text] [Related]
40. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.
Iwata S; Yamaguchi N; Munakata Y; Ikushima H; Lee JF; Hosono O; Schlossman SF; Morimoto C
Int Immunol; 1999 Mar; 11(3):417-26. PubMed ID: 10221653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
